DISH May Signal Elevated Diabetes Risk in Cardiovascular Disease Patients, Study Finds

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-06-22 15:30 GMT   |   Update On 2025-06-22 15:30 GMT

Netherlands: A new study from the Netherlands suggests that diffuse idiopathic skeletal hyperostosis (DISH), a condition marked by abnormal calcification and ossification along the spine, could be a valuable imaging marker for predicting the onset of type 2 diabetes mellitus (T2DM) in patients with cardiovascular disease.

Published in Rheumatology, the research led by Dr. Netanja I. Harlianto and colleagues from the Department of Radiology at University Medical Center Utrecht assessed the potential of DISH as a predictor for future diabetes in a large cohort of heart patients. The findings point to a significantly higher risk of developing T2DM in individuals with DISH compared to those without the condition.

The study included 3,395 individuals from the ongoing Second Manifestation of ARTerial disease (SMART) cohort, all of whom had established cardiovascular disease but no prior diagnosis of diabetes at the time of enrollment. Chest X-rays were used to detect DISH at baseline, applying Resnick’s criteria to confirm the diagnosis. Over a median follow-up period of 11.1 years, 317 participants developed type 2 diabetes.

The study revealed the following findings:

  • DISH was detected in 263 patients, representing 7.7% of the total study cohort.
  • Patients with DISH had a diabetes incidence rate of 17.1 per 1,000 person-years, more than double that of those without DISH (7.8 per 1,000 person-years).
  • After adjusting for conventional diabetes risk factors like obesity, hypertension, and hyperlipidemia, DISH still showed an independent association with a higher risk of developing type 2 diabetes.
  • The adjusted incidence rate ratio (IRR) for patients with DISH was 1.47 (95% CI: 1.03–2.06).
  • Individuals with more extensive spinal ossification had an even higher risk, with an IRR of 2.01 (95% CI: 1.15–3.29).
  • The number needed to screen (NNS) over 11 years to detect one new case of diabetes in patients with DISH was 7.
  • This NNS is comparable to other established diabetes risk markers such as obesity (NNS = 5), hypertension (NNS = 9), and hyperlipidemia (NNS = 13).

These findings emphasize the potential clinical value of using routine imaging results, often obtained for other reasons, as an early warning signal for metabolic disease. The authors propose that the incidental detection of DISH on chest radiographs could prompt more proactive diabetes screening and intervention in patients with cardiovascular disease.

"The study highlights DISH as a novel, imaging-based risk indicator for type 2 diabetes in individuals with cardiovascular disease. Incorporating DISH into routine risk assessments could enhance early identification and management of diabetes in this vulnerable population," the authors concluded.

Reference:

Harlianto, N. I., Foppen, W., Mohamed Hoesein, F. A., Hol, M. E., Verlaan, J., De Jong, P. A., Westerink, J., Cramer, M. J., G, M., Nathoe, H. M., Van Setten, J., Teraa, M., C, N., Van Smeden, M., H, M., De Jong, P. A., Lely, A. T., Haitjema, S., Mokhles, M. M., . . . Visseren, F. L. Diffuse idiopathic skeletal hyperostosis as a marker for incident diabetes mellitus in cardiovascular disease patients. Rheumatology. https://doi.org/10.1093/rheumatology/keaf268


Tags:    
Article Source : Rheumatology journal

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Medical Bulletin 18/June/2025

Medical Bulletin 17/June/2025